Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy (Molecular Neurodegeneration)

Passive immunotherapies targeting Aβ continue to be evaluated as Alzheimer`s disease (AD) therapeutics, but there remains debate over the mechanisms by which these immunotherapies work. Besides the amount of p...